Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease
Hypertension is a risk factor for cardiovascular disease. Increased urinary sodium excretion, representing dietary sodium intake, is associated with hypertension. Low sodium intake has been associated with increased mortality in observational studies. Further studies should assess whether confoundin...
Saved in:
Published in | Hypertension (Dallas, Tex. 1979) Vol. 73; no. 6; pp. 1202 - 1209 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Heart Association, Inc
01.06.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 0194-911X 1524-4563 1524-4563 |
DOI | 10.1161/HYPERTENSIONAHA.119.12726 |
Cover
Abstract | Hypertension is a risk factor for cardiovascular disease. Increased urinary sodium excretion, representing dietary sodium intake, is associated with hypertension. Low sodium intake has been associated with increased mortality in observational studies. Further studies should assess whether confounding relationships explain associations between sodium intake and outcomes. We studied UK Biobank participants (n=457 484; mean age, 56.3 years; 44.7% men) with urinary electrolytes and blood pressure data. Estimated daily urinary sodium excretion was calculated using Kawasaki formulae. We analyzed associations between sodium excretion and blood pressure in subjects without cardiovascular disease, treated hypertension, or diabetes mellitus at baseline (n=322 624). We tested relationships between sodium excretion, incidence of fatal and nonfatal cardiovascular disease, heart failure, and mortality. Subjects in higher quintiles of sodium excretion were younger, with more men and higher body mass index. There was a linear relationship between increasing urinary sodium excretion and blood pressure. During median follow-up of 6.99 years, there were 11 932 deaths (1125 cardiovascular deaths) with 10 717 nonfatal cardiovascular events. There was no relationship between quintile of sodium excretion and outcomes. These relationships were unchanged after adjustment for comorbidity or excluding subjects with events during the first 2 years follow-up. No differing risk of incident heart failure (1174 events) existed across sodium excretion quintiles. Urinary sodium excretion correlates with elevated blood pressure in subjects at low cardiovascular risk. No pattern of increased cardiovascular disease, heart failure, or mortality risk was demonstrated with either high or low sodium intake. |
---|---|
AbstractList | Hypertension is a risk factor for cardiovascular disease. Increased urinary sodium excretion, representing dietary sodium intake, is associated with hypertension. Low sodium intake has been associated with increased mortality in observational studies. Further studies should assess whether confounding relationships explain associations between sodium intake and outcomes. We studied UK Biobank participants (n=457 484; mean age, 56.3 years; 44.7% men) with urinary electrolytes and blood pressure data. Estimated daily urinary sodium excretion was calculated using Kawasaki formulae. We analyzed associations between sodium excretion and blood pressure in subjects without cardiovascular disease, treated hypertension, or diabetes mellitus at baseline (n=322 624). We tested relationships between sodium excretion, incidence of fatal and nonfatal cardiovascular disease, heart failure, and mortality. Subjects in higher quintiles of sodium excretion were younger, with more men and higher body mass index. There was a linear relationship between increasing urinary sodium excretion and blood pressure. During median follow-up of 6.99 years, there were 11 932 deaths (1125 cardiovascular deaths) with 10 717 nonfatal cardiovascular events. There was no relationship between quintile of sodium excretion and outcomes. These relationships were unchanged after adjustment for comorbidity or excluding subjects with events during the first 2 years follow-up. No differing risk of incident heart failure (1174 events) existed across sodium excretion quintiles. Urinary sodium excretion correlates with elevated blood pressure in subjects at low cardiovascular risk. No pattern of increased cardiovascular disease, heart failure, or mortality risk was demonstrated with either high or low sodium intake. Hypertension is a risk factor for cardiovascular disease. Increased urinary sodium excretion, representing dietary sodium intake, is associated with hypertension. Low sodium intake has been associated with increased mortality in observational studies. Further studies should assess whether confounding relationships explain associations between sodium intake and outcomes. We studied UK Biobank participants (n=457 484; mean age, 56.3 years; 44.7% men) with urinary electrolytes and blood pressure data. Estimated daily urinary sodium excretion was calculated using Kawasaki formulae. We analyzed associations between sodium excretion and blood pressure in subjects without cardiovascular disease, treated hypertension, or diabetes mellitus at baseline (n=322 624). We tested relationships between sodium excretion, incidence of fatal and nonfatal cardiovascular disease, heart failure, and mortality. Subjects in higher quintiles of sodium excretion were younger, with more men and higher body mass index. There was a linear relationship between increasing urinary sodium excretion and blood pressure. During median follow-up of 6.99 years, there were 11 932 deaths (1125 cardiovascular deaths) with 10 717 nonfatal cardiovascular events. There was no relationship between quintile of sodium excretion and outcomes. These relationships were unchanged after adjustment for comorbidity or excluding subjects with events during the first 2 years follow-up. No differing risk of incident heart failure (1174 events) existed across sodium excretion quintiles. Urinary sodium excretion correlates with elevated blood pressure in subjects at low cardiovascular risk. No pattern of increased cardiovascular disease, heart failure, or mortality risk was demonstrated with either high or low sodium intake.Hypertension is a risk factor for cardiovascular disease. Increased urinary sodium excretion, representing dietary sodium intake, is associated with hypertension. Low sodium intake has been associated with increased mortality in observational studies. Further studies should assess whether confounding relationships explain associations between sodium intake and outcomes. We studied UK Biobank participants (n=457 484; mean age, 56.3 years; 44.7% men) with urinary electrolytes and blood pressure data. Estimated daily urinary sodium excretion was calculated using Kawasaki formulae. We analyzed associations between sodium excretion and blood pressure in subjects without cardiovascular disease, treated hypertension, or diabetes mellitus at baseline (n=322 624). We tested relationships between sodium excretion, incidence of fatal and nonfatal cardiovascular disease, heart failure, and mortality. Subjects in higher quintiles of sodium excretion were younger, with more men and higher body mass index. There was a linear relationship between increasing urinary sodium excretion and blood pressure. During median follow-up of 6.99 years, there were 11 932 deaths (1125 cardiovascular deaths) with 10 717 nonfatal cardiovascular events. There was no relationship between quintile of sodium excretion and outcomes. These relationships were unchanged after adjustment for comorbidity or excluding subjects with events during the first 2 years follow-up. No differing risk of incident heart failure (1174 events) existed across sodium excretion quintiles. Urinary sodium excretion correlates with elevated blood pressure in subjects at low cardiovascular risk. No pattern of increased cardiovascular disease, heart failure, or mortality risk was demonstrated with either high or low sodium intake. |
Author | Welsh, Paul Iliodromiti, S. Mark, Patrick B. Lewsey, J.D. Sattar, Naveed Welsh, C.E. Delles, Christian Gill, J.M.R. Jhund, Pardeep Celis-Morales, C. Gray, S. Lyall, D. |
AuthorAffiliation | From the Institute of Cardiovascular and Medical Sciences (C.E.W., P.W., P.J., C.D., C.C.-M., S.G., J.M.R.G., N.S., P.B.M.) Institute of Health and Wellbeing (J.D.L., D.L.), University of Glasgow, United Kingdom Women’s Health Research Division, Queen Mary University of London, United Kingdom (S.I.) |
AuthorAffiliation_xml | – name: From the Institute of Cardiovascular and Medical Sciences (C.E.W., P.W., P.J., C.D., C.C.-M., S.G., J.M.R.G., N.S., P.B.M.) Institute of Health and Wellbeing (J.D.L., D.L.), University of Glasgow, United Kingdom Women’s Health Research Division, Queen Mary University of London, United Kingdom (S.I.) |
Author_xml | – sequence: 1 givenname: C.E. surname: Welsh fullname: Welsh, C.E. organization: From the Institute of Cardiovascular and Medical Sciences (C.E.W., P.W., P.J., C.D., C.C.-M., S.G., J.M.R.G., N.S., P.B.M.) Institute of Health and Wellbeing (J.D.L., D.L.), University of Glasgow, United Kingdom Women’s Health Research Division, Queen Mary University of London, United Kingdom (S.I.) – sequence: 2 givenname: Paul surname: Welsh fullname: Welsh, Paul – sequence: 3 givenname: Pardeep surname: Jhund fullname: Jhund, Pardeep – sequence: 4 givenname: Christian surname: Delles fullname: Delles, Christian – sequence: 5 givenname: C. surname: Celis-Morales fullname: Celis-Morales, C. – sequence: 6 givenname: J.D. surname: Lewsey fullname: Lewsey, J.D. – sequence: 7 givenname: S. surname: Gray fullname: Gray, S. – sequence: 8 givenname: D. surname: Lyall fullname: Lyall, D. – sequence: 9 givenname: S. surname: Iliodromiti fullname: Iliodromiti, S. – sequence: 10 givenname: J.M.R. surname: Gill fullname: Gill, J.M.R. – sequence: 11 givenname: Naveed surname: Sattar fullname: Sattar, Naveed – sequence: 12 givenname: Patrick surname: Mark middlename: B. fullname: Mark, Patrick B. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31067194$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkV9PFDEUxRuDkQX9Cqa--cBg2-nOTB-MWdfFJUEgLER9mnTb22yhO8X-EfkafmILiz6QmPB0k3N_5zycs4O2Bj8AQm8o2ae0oe_m309nZ-ez48XhyfFkPimi2KesZc0zNKJjxis-buotNCJU8EpQ-m0b7cR4SQjlnLcv0HZNSdOW5wj9vgh2kOEWL7y2eY1nv1SAZP2whz867zU-DRBjDrCH5aDxmY1X2Bt8kFPR8FQGbf1PGVV2MuBPNoKMcE9-8SFJZ9MttgNe5OUlqBTxV5tWPqeSan34j_0lem6ki_Dq4e6ii4PZ-XReHZ18PpxOjirFu66poDUdaTmQbiy0aYhsecMoEW3HqNRNy0g9llKZZWc4NUybThqmNCG6awwIVe-it5vc6-B_ZIipX9uowDk5gM-xZ6ymgtSUkoK-fkDzcg26vw52XUrr__ZYALEBVPAxBjD_EEr6u836R5sVUfT3mxXvh0deZZO82yAFad2TEt5vEm68SxDilcs3EPoVSJdWT_D_AdTntdI |
CitedBy_id | crossref_primary_10_1161_HYPERTENSIONAHA_119_13349 crossref_primary_10_3389_fcvm_2024_1418059 crossref_primary_10_1016_S0140_6736_19_32008_2 crossref_primary_10_1161_CIRCRESAHA_121_318083 crossref_primary_10_1016_j_ekir_2020_05_025 crossref_primary_10_1161_JAHA_119_014978 crossref_primary_10_1016_j_ihj_2023_12_005 crossref_primary_10_1186_s40885_023_00259_0 crossref_primary_10_1161_JAHA_123_030353 crossref_primary_10_3390_nu12113442 crossref_primary_10_1111_joim_13194 crossref_primary_10_1002_bab_2383 crossref_primary_10_1177_1559827620915708 crossref_primary_10_3390_ijerph17082811 crossref_primary_10_1017_S0007114521001768 crossref_primary_10_3390_nu13093232 crossref_primary_10_4162_nrp_2023_17_2_175 crossref_primary_10_1038_s41598_022_09852_z crossref_primary_10_3389_fpubh_2022_857818 crossref_primary_10_3390_nu15234898 crossref_primary_10_1161_JAHA_122_026578 crossref_primary_10_1038_s41581_021_00533_0 crossref_primary_10_1161_HYPERTENSIONAHA_120_16668 crossref_primary_10_1097_HJH_0000000000003959 crossref_primary_10_1111_joim_13233 crossref_primary_10_1016_j_jjcc_2021_04_013 crossref_primary_10_1161_HYPERTENSIONAHA_120_16549 crossref_primary_10_1016_j_isci_2023_106728 crossref_primary_10_1002_smll_202403385 crossref_primary_10_1186_s12916_022_02691_9 crossref_primary_10_1016_j_jeem_2024_102954 crossref_primary_10_2147_DMSO_S337032 crossref_primary_10_1371_journal_pone_0265429 crossref_primary_10_1093_eurheartj_ehaa586 crossref_primary_10_3389_fendo_2023_1124479 crossref_primary_10_3389_fnut_2024_1395016 crossref_primary_10_15829_1728_8800_2020_2612 crossref_primary_10_1007_s00394_021_02595_z crossref_primary_10_1161_HYPERTENSIONAHA_119_13321 crossref_primary_10_1093_advances_nmaa049 crossref_primary_10_1038_s41430_023_01354_z crossref_primary_10_1097_MD_0000000000040497 crossref_primary_10_1016_j_semnephrol_2023_151407 crossref_primary_10_1038_s41598_020_74657_x crossref_primary_10_1017_S0007114520004122 crossref_primary_10_3390_nu13093177 crossref_primary_10_1016_j_appr_2021_100091 crossref_primary_10_1001_jamacardio_2024_5410 crossref_primary_10_1093_eurheartj_ehac599 crossref_primary_10_3390_nu12113591 crossref_primary_10_1038_s41591_024_03010_w crossref_primary_10_1161_HYPERTENSIONAHA_119_13818 crossref_primary_10_1097_HJH_0000000000002647 crossref_primary_10_1161_HYPERTENSIONAHA_119_14028 crossref_primary_10_1161_HYPERTENSIONAHA_119_14302 crossref_primary_10_1093_ehjopen_oead024 crossref_primary_10_1186_s12872_025_04619_6 crossref_primary_10_5334_gh_1187 |
Cites_doi | 10.1136/bmj.f1326 10.1016/0021-9681(87)90171-8 10.1001/jama.2011.574 10.1161/CIRCULATIONAHA.117.029193 10.1056/NEJMoa1311889 10.1161/HYPERTENSIONAHA.111.00566 10.1172/JCI88530 10.1161/CIR.0000000000000485 10.1681/ASN.2016060662 10.1111/j.1440-1681.1993.tb01496.x 10.1016/S0140-6736(09)60144-6 10.1136/bmj.f1325 10.1001/jama.2011.1729 10.2337/dc10-1722 10.1056/NEJMoa1311989 10.1161/01.CIR.49.6.1132 10.1161/01.HYP.25.6.1144 10.1016/j.jamda.2017.09.004 10.1016/S0140-6736(18)31724-0 10.1038/ki.2013.367 10.1002/14651858.CD004022.pub4 10.1371/journal.pmed.1001779 10.1161/01.cir.0000437740.48606.d1 10.1016/S0140-6736(16)31134-5 10.1161/HYPERTENSIONAHA.118.11103 10.1161/01.CIR.77.1.53 10.1001/jama.2016.4447 10.1093/eurheartj/ehx035 10.1056/NEJMra064486 10.2337/dc10-1723 10.1056/NEJM200101043440101 10.1093/oxfordjournals.aje.a116012 10.1097/HJH.0000000000000122 10.1016/S0140-6736(18)31376-X |
ContentType | Journal Article |
Copyright | 2019 American Heart Association, Inc |
Copyright_xml | – notice: 2019 American Heart Association, Inc |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1161/HYPERTENSIONAHA.119.12726 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4563 |
EndPage | 1209 |
ExternalDocumentID | 31067194 10_1161_HYPERTENSIONAHA_119_12726 10.1161/HYPERTENSIONAHA.119.12726 |
Genre | Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
GeographicLocations | United Kingdom |
GeographicLocations_xml | – name: United Kingdom |
GrantInformation_xml | – fundername: Medical Research Council grantid: MR/N015177/1 – fundername: Medical Research Council grantid: MR/N015177/2 |
GroupedDBID | --- .-D .3C .55 .GJ .XZ .Z2 01R 0R~ 18M 1J1 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AAXQO AAYEP ABASU ABBUW ABDIG ABJNI ABOCM ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFFNX AFNMH AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BCGUY BOYCO BQLVK BS7 C1A C45 CS3 DIK DIWNM DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI KQ8 L-C L7B N4W N9A N~7 N~B N~M O9- OAG OAH OB3 OCUKA ODA ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YHZ YOC YYM YYP ZFV ZGI ZZMQN AAYXX ADGHP CITATION CGR CUY CVF ECM EIF NPM OZ- 7X8 ADKSD ADSXY |
ID | FETCH-LOGICAL-c4886-e7f8074e0859df60a74621097821ad672035aacfb8f41f2df8af2cd00d86fe9c3 |
ISSN | 0194-911X 1524-4563 |
IngestDate | Mon Sep 08 05:40:26 EDT 2025 Mon Jul 21 06:02:47 EDT 2025 Thu Apr 24 23:02:53 EDT 2025 Tue Jul 01 01:45:03 EDT 2025 Fri May 16 03:49:32 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | blood pressure heart failure sodium cardiovascular diseases diet |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4886-e7f8074e0859df60a74621097821ad672035aacfb8f41f2df8af2cd00d86fe9c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.119.12726 |
PMID | 31067194 |
PQID | 2231903110 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2231903110 pubmed_primary_31067194 crossref_primary_10_1161_HYPERTENSIONAHA_119_12726 crossref_citationtrail_10_1161_HYPERTENSIONAHA_119_12726 wolterskluwer_health_10_1161_HYPERTENSIONAHA_119_12726 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-June 2019-06-00 20190601 |
PublicationDateYYYYMMDD | 2019-06-01 |
PublicationDate_xml | – month: 06 year: 2019 text: 2019-June |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Hypertension (Dallas, Tex. 1979) |
PublicationTitleAlternate | Hypertension |
PublicationYear | 2019 |
Publisher | American Heart Association, Inc |
Publisher_xml | – name: American Heart Association, Inc |
References | e_1_3_4_3_2 e_1_3_4_2_2 e_1_3_4_9_2 e_1_3_4_8_2 e_1_3_4_7_2 e_1_3_4_6_2 e_1_3_4_5_2 e_1_3_4_4_2 e_1_3_4_23_2 e_1_3_4_20_2 e_1_3_4_21_2 e_1_3_4_26_2 e_1_3_4_27_2 e_1_3_4_24_2 e_1_3_4_25_2 e_1_3_4_28_2 e_1_3_4_29_2 e_1_3_4_30_2 Townsend P PM (e_1_3_4_17_2) 1988 Mancilha-Carvalho JJ (e_1_3_4_22_2) 1989; 3 e_1_3_4_11_2 e_1_3_4_34_2 e_1_3_4_12_2 e_1_3_4_33_2 e_1_3_4_32_2 e_1_3_4_10_2 e_1_3_4_31_2 e_1_3_4_15_2 e_1_3_4_16_2 e_1_3_4_37_2 e_1_3_4_13_2 e_1_3_4_36_2 e_1_3_4_14_2 e_1_3_4_35_2 e_1_3_4_19_2 e_1_3_4_18_2 31230541 - Hypertension. 2019 Aug;74(2):e26. doi: 10.1161/HYPERTENSIONAHA.119.13321. 31230548 - Hypertension. 2019 Aug;74(2):e27-e28. doi: 10.1161/HYPERTENSIONAHA.119.13349. |
References_xml | – ident: e_1_3_4_9_2 doi: 10.1136/bmj.f1326 – ident: e_1_3_4_19_2 doi: 10.1016/0021-9681(87)90171-8 – ident: e_1_3_4_13_2 doi: 10.1001/jama.2011.574 – ident: e_1_3_4_6_2 doi: 10.1161/CIRCULATIONAHA.117.029193 – ident: e_1_3_4_11_2 doi: 10.1056/NEJMoa1311889 – ident: e_1_3_4_35_2 doi: 10.1161/HYPERTENSIONAHA.111.00566 – ident: e_1_3_4_37_2 doi: 10.1172/JCI88530 – ident: e_1_3_4_2_2 doi: 10.1161/CIR.0000000000000485 – ident: e_1_3_4_36_2 doi: 10.1681/ASN.2016060662 – ident: e_1_3_4_18_2 doi: 10.1111/j.1440-1681.1993.tb01496.x – ident: e_1_3_4_33_2 doi: 10.1016/S0140-6736(09)60144-6 – ident: e_1_3_4_8_2 doi: 10.1136/bmj.f1325 – ident: e_1_3_4_12_2 doi: 10.1001/jama.2011.1729 – ident: e_1_3_4_26_2 doi: 10.2337/dc10-1722 – ident: e_1_3_4_4_2 doi: 10.1056/NEJMoa1311989 – ident: e_1_3_4_23_2 doi: 10.1161/01.CIR.49.6.1132 – ident: e_1_3_4_24_2 doi: 10.1161/01.HYP.25.6.1144 – ident: e_1_3_4_27_2 doi: 10.1016/j.jamda.2017.09.004 – ident: e_1_3_4_14_2 doi: 10.1016/S0140-6736(18)31724-0 – ident: e_1_3_4_34_2 doi: 10.1038/ki.2013.367 – ident: e_1_3_4_29_2 doi: 10.1002/14651858.CD004022.pub4 – ident: e_1_3_4_16_2 doi: 10.1371/journal.pmed.1001779 – ident: e_1_3_4_10_2 doi: 10.1161/01.cir.0000437740.48606.d1 – ident: e_1_3_4_3_2 doi: 10.1016/S0140-6736(16)31134-5 – ident: e_1_3_4_31_2 doi: 10.1161/HYPERTENSIONAHA.118.11103 – volume-title: Health and Deprivation. Inequality and the North year: 1988 ident: e_1_3_4_17_2 – volume: 3 start-page: 309 year: 1989 ident: e_1_3_4_22_2 article-title: Blood pressure and electrolyte excretion in the Yanomamo Indians, an isolated population. publication-title: J Hum Hypertens – ident: e_1_3_4_5_2 doi: 10.1161/01.CIR.77.1.53 – ident: e_1_3_4_25_2 doi: 10.1001/jama.2016.4447 – ident: e_1_3_4_30_2 doi: 10.1093/eurheartj/ehx035 – ident: e_1_3_4_20_2 doi: 10.1056/NEJMra064486 – ident: e_1_3_4_28_2 doi: 10.2337/dc10-1723 – ident: e_1_3_4_7_2 doi: 10.1056/NEJM200101043440101 – ident: e_1_3_4_21_2 doi: 10.1093/oxfordjournals.aje.a116012 – ident: e_1_3_4_32_2 doi: 10.1097/HJH.0000000000000122 – ident: e_1_3_4_15_2 doi: 10.1016/S0140-6736(18)31376-X – reference: 31230548 - Hypertension. 2019 Aug;74(2):e27-e28. doi: 10.1161/HYPERTENSIONAHA.119.13349. – reference: 31230541 - Hypertension. 2019 Aug;74(2):e26. doi: 10.1161/HYPERTENSIONAHA.119.13321. |
SSID | ssj0014447 |
Score | 2.5314796 |
Snippet | Hypertension is a risk factor for cardiovascular disease. Increased urinary sodium excretion, representing dietary sodium intake, is associated with... |
SourceID | proquest pubmed crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1202 |
SubjectTerms | Biomarkers - urine Blood Pressure - physiology Cardiovascular Diseases - mortality Cardiovascular Diseases - physiopathology Cardiovascular Diseases - urine Cause of Death - trends Female Humans Male Middle Aged Retrospective Studies Risk Assessment - methods Risk Factors Sodium - urine Survival Rate - trends United Kingdom - epidemiology |
Title | Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31067194 https://www.proquest.com/docview/2231903110 |
Volume | 73 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1da9swFBVZB6FjjH0v-0KFvbXOYtmR7cdsTQmFlsIa2j0Z2ZJottUObsLKfsb-yf7h7pVk1-ka1u0lBCWSIfdEOlc654qQd5JpLFIUeDnPIEHhgfTiPMq8LErYMFAiygdocD445JNpuH86PO10frVUS8tF1s9_3Ogr-Z-oQhvEFV2y_xDZZlBogPcQX3iFCMPrrWI8rayb9lMpZ8vz7fFljp5Ee47-ARXpzv1n95mNFdEpyfdMKRGUe7TVqLv2tMaKLwwvR44-K3B6-WJkHyezxRkqmY-qWVmt6d7muxNIcysjkjcoi3dx394qk9Rlf9tPoqS1F3ECC7U98rkySDRtbQ3j_tmycAS4kkrNGzqOxxCtogk19t22BjqpavlVX7mpmIUe0LugPVfba08cJtsTr8-McfuGFYHjijD5fDSG_OAQF6jRZATNSd9nkTXrt5AyPzdQCbCwnm9vX75Wjrv-6A65yyKga-gvP21URZCehlGXbLknv1_73E3SrUdaZUR_pDn3yP3vJSonLr4a40SL_hw_JA9c3kJHFoSPSEcVj0n3wCkznpCfDovUYpE2WNyhBom0RuIOBXRRxCEtNbU4pKtAog5I5psNDumsoDUOqcMhNThc0_0pme6Njz9OPHffh5fDMsI9FWkszaSw5p7UfCCikDNUSMTMF5KjYGAoRK6zWIe-ZlLHQrNcDgYy5lolefCMbBRloV4QmmgpJNBT5SsfcvqhCIUKQsmFzpDzxj0S1795mrti-Hgny7fUJMXcT69FDhqT1ESuR1jTdW4rwtym01Yd2BTmbzyUE4Uqlxcp0HPg5AGw8B55biPeDFsjpEf4CgRS65H--2Nfrh3yFdm8-te9JhuLaqneAL1eZG8NoH8D4JbOSQ |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Urinary+Sodium+Excretion%2C+Blood+Pressure%2C+and+Risk+of+Future+Cardiovascular+Disease+and+Mortality+in+Subjects+Without+Prior+Cardiovascular+Disease&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=Welsh%2C+C+E&rft.au=Welsh%2C+Paul&rft.au=Jhund%2C+Pardeep&rft.au=Delles%2C+Christian&rft.date=2019-06-01&rft.eissn=1524-4563&rft.volume=73&rft.issue=6&rft.spage=1202&rft_id=info:doi/10.1161%2FHYPERTENSIONAHA.119.12726&rft_id=info%3Apmid%2F31067194&rft.externalDocID=31067194 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon |